EnteroBiotix article features in the European Biopharmaceutical Review

EnteroBiotix in the news
Written By James McIlroy

Encapsulating and Enhancing the Microbiome - A New Era for Microbe-Based Medicines

EnteroBiotix article features in the European Biopharmaceutical Review

Thank you to European Biopharmaceutical Review (EBR) for publishing this informative article on ‘Encapsulating and Enhancing the Microbiome - A New Era for Microbe-Based Medicines’, authored by our CEO Dr James McIlroy.

A new age is approaching for pharmaceutical medicines that improve the gut microbiome to prevent and treat diseases caused by microbes. Along with these advancements, more public awareness of how diet can support gut health will be critical.

Take a look at the article here

James McIlroy
Previous

EnteroBiotix receives MHRA MIA (IMP) licensure of state-of-the-art GMP manufacturing facility for producing microbiome therapeutics
Next

EnteroBiotix CEO features on Labiotech’s Beyond Biotech podcast talking about mastering the microbiome